Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Net Equity Issued and Repurchased (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMAA) recorded Net Equity Issued and Repurchased of $232.05 million in FY2025, compared with $35,000 in FY2024.

Analysis

Drugs Made In America Acquisition (DMAA) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

  • Per Business Quant data, DMAA's Net Equity Issued and Repurchased was $35,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 39.00 Mn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - -109.16 Mn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn -143.10 Mn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - -10.00 Mn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -118.00 Mn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 996,000.00
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn -7.40 Mn
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 8.30 Mn
Mar 31, 2025 232.05 Mn
Sep 30, 2024 35,000.00
API Access

Drugs Made In America Acquisition Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DMAA&period=max&api_key=YOUR_API_KEY